Dosing for Indian Polyvalent Antivenom in Venomous Snake Bite
The recommended initial dose of Indian polyvalent antivenom (IPAV) is 100 mL (10 vials) administered intravenously over 15 minutes, with repeat doses of 100 mL every 6 hours until the 20-minute whole blood clotting time (20WBCT) normalizes, up to a maximum of 300 mL total. 1
Initial Administration
The FDA-approved dosing for IPAV specifies that the entire contents of a restored single-dose vial (2.5 mL) should be given, though this refers to the older formulation 1. In current Indian clinical practice, the standard approach is:
- Initial bolus: 100 mL (10 vials) IV over 15 minutes
- Route: Intravenous administration is preferred, diluted in 10-50 mL of normal saline 1
- Alternative: Intramuscular injection in the anterolateral thigh is acceptable but less preferred 1
Repeat Dosing Protocol
Monitor 20WBCT every 6 hours and repeat 100 mL doses until coagulation normalizes 2. The National Protocol recommends:
- Continue 100 mL every 6 hours until 20WBCT becomes negative
- Maximum total dose: 300 mL (30 vials) 2
- Stop when clotting time normalizes, whichever comes first
Important Caveats
Approximately 35% of patients experience recurrence of coagulation dysfunction after initial correction 3. Therefore:
- Continue monitoring 20WBCT even after normalization
- Be prepared to administer additional doses if coagulopathy recurs
- Patients with incoagulable blood at presentation may require higher initial doses (150-200 mL) 3
Evidence-Based Dosing Considerations
Recent research challenges the high-dose approach. Multiple studies 4, 5, 6 demonstrate that lower doses (40-70 mL initial, followed by 30 mL every 6 hours) are equally effective with similar mortality and morbidity outcomes. However, the FDA-approved labeling and National Protocol still recommend the higher dosing regimen 1, 2.
The critical factor is early administration rather than dose size 7. Antivenom should be given within the first few hours of envenomation when systemic symptoms appear (nausea, vomiting, headache, abdominal pain) to prevent irreversible effects.
Pre-Administration Requirements
Mandatory skin testing before administration 1:
- Inject 0.02 mL of 1:10 dilution of normal horse serum intradermally
- Positive reaction: urticarial wheal with erythema within 10 minutes
- If positive, desensitization protocol required
Have epinephrine 1:1000 immediately available (0.3-1.0 mL subcutaneously for adults, 0.05-0.1 mL IV) 1. Hypersensitivity reactions occur in over 50% of patients receiving antivenom 8.
Specific Clinical Scenarios
For hemotoxic envenomation (viper bites with coagulopathy):
- Initial 100 mL, then 100 mL every 6 hours until 20WBCT normalizes 2
- Patients with incoagulable blood at entry require 150-200 mL initially 3
For neurotoxic envenomation (cobra/krait bites):
- 150 mL initial dose is as effective as higher doses 4
- Continue until neurological recovery, though antivenom has limited effect on established pre-synaptic neurotoxicity 7
Critical Limitations
IPAV has significant limitations 8, 9:
- Only effective against the "Big Four" snakes (Naja naja, Echis carinatus, Daboia russelli, Bungarus caeruleus)
- Ineffective against hump-nosed pit viper and many other Indian species
- Does not reverse established myotoxicity or pre-synaptic neurotoxicity
- High rate of hypersensitivity reactions (>50%)
Monitor for serum sickness for 8-12 days post-administration 1.